Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (4798)	7/12/1998 2:43:00 AM
From: Bill Wexler	Read Replies (1) \| Respond to of 7041

<<Good job Bill>> Thanks. <<You copied three of my 1000 plus posts on SI>> I was pointing out how you were 100% wrong about TXB, right after you claimed that I'm not qualified to interpret test results. <<You also did not post your statements that I was responding to, which were irresponsible distortions>> Now I can call you a liar Brad. My posts weren't "irresponsible distortions", they were accurate analysis...directly verified by the fact that Novastan was indeed rejected and the stock fell into the toilet. By the way, any moron can check the statements you were responding to simply by clicking on the link at the top of the message. Give me a break. <<As I just told you, I sold TXB for a profit.>> Interesting. How long were you holding it? Did you sell before or after FDA rejection? <<As I have said repeatedly on this thread, I do not have a position in ZONA>> You certainly seem to be spending a lot of time here then. At least I have an excuse - I have a growing short position in Zonagen. <<Vasomax might get approved and it might not>> Vasomax will never be approved for the simple, and obvious, reason that oral phentolamine is ineffective for the treatment of ED. <<I certainly don't agree with trying to destroy the company, like you seem to be trying to do>> Beyond my purely selfish reasons (i.e. I profit when the stock tanks), I simply don't like crooks. Despite the fact that nearly all of my posts involve exposing scams like Zonagen, the majority of my portfolio is long in high-quality companies. I believe that stock frauds like Zonagen steal capital from sincere entrepreneurs. While I place Zonagen at Cockroach level, at least they aren't Cockroach excrement like HEPH - who are stealing money from small investors by fraudulently promoting a phony AIDS medication. Congratulations go to Zonagen management for this moral triumph. <<You distorted the facts concerning the patent and the clinical trials.>> Correction Brad. TXB management distorted the trials. TXB management has dealt with scumbag stock promoters like David Blech, so the fact that they pulled a fast one in clinical trials doesn't surprise me. A past history of unethical behavior is one of the biggest red flags a short-seller looks for. Zonagen...Immumax...hint...hint. <<Whether you turn out to be right or wrong concerning the ultimate fate of ZONA, you still distorted the facts. You did the same thing on TXB.>> I was, am, and will continue to be 100% correct about the Zonagen fraud. My analysis of this company is true and correct, which means I have a better grasp of the facts than you could ever hope for. I love this Orwellian double-think-spin that you and Lamestone came up with. Even though all publicly available information clearly demonstrates I was absolutely correct about KRY, and the stock is now in the toilet as a result...Lamestone unbelievably continues to insist that I was wrong. TXB's shoddy drug candidate, Novastan, was rejected by the FDA and the stock is now in the toilet - and now YOU are claiming that I "distorted the facts". I can hardly wait for your next brilliant post. Please oh please don't make us wait too long.